The compatibility of immunolabeling with STR profiling

Short Tandem Repeat DNA Profiling Using Perylene-Oligonucleotide Fluorescence Assay

We report an amplification-free genotyping method to determine the number of human short tandem repeats (STRs). DNA-based STR profiling is a robust method for genetic identification purposes such as forensics and biobanking and for identifying specific molecular subtypes of cancer. STR detection requires polymerase amplification, which introduces errors that obscure the correct genotype. We developed a new method that requires no polymerase. First, we synthesized perylene-nucleoside reagents and incorporated them into oligonucleotide probes that recognize five common human STRs. Using these probes and a bead-based hybridization approach, accurate STR detection was achieved in only 1.5 h, including DNA preparation steps, with up to a 1000-fold target DNA enrichment. This method was comparable to PCR-based assays. Using standard fluorometry, the limit of detection was 2.00 ± 0.07 pM for a given target. We used this assay to accurately identify STRs from 50 human subjects, achieving >98% consensus with sequencing data for STR genotyping.

Recent Progress in Visualization and Analysis of Fingerprint Level 3 Features

Fingerprints provide sufficient and reliable discriminative characteristics which have been considered one of the most robust evidence for individualization. The limitation of current minutiae-based fingerprint technology seems to be solved with the development of level 3 features since they can offer additional information for problematic fingerprint recognition and even donor profiling. So far, tremendous efforts have been devoted to detecting and analysing the third-level details. This review summarizes the advances in level 3 details with an emphasis on their reliability assessment, visualization methods based on physical interaction, residue-response, mass spectrometry and electrochemical techniques, as well as the potentiality for individualization, donor profiling and even other application scenarios. In the end, we also give a personal perspective on the future direction and the remaining challenges in the third-level-detail-related field. We believe that the new exciting progress is expected in the development of level 3 detail detection and analysis with continued interest and attention to this field.

Improving the visualization of fingermarks using multi-target immunolabeling

The development of fingermarks is an important step in visualizing ridge patterns for individualization purposes. Immunolabeling can be applied to fingermarks to selectively and sensitively detect antigens in fingermarks, and can be used as a developing method to visualize fingermarks. In this study we investigated single (the detection of one antigen) and multiple targeting approaches (the detection of multiple antigens simultaneously) to improve fingermark development. The detection of dermcidin, an antimicrobial peptide, was used as the gold standard to compare single and multi-target detection of keratins, albumin and/or dermcidin. Single detection of dermcidin and albumin mostly resulted in clear ridge details and/or pore detection, whereas the single keratin detection resulted in a poor visualization of the fingermarks. The multi-target approach in which both dermcidin and albumin were targeted, resulted in improved fingermark development compared to single dermcidin detection. Therefore, we recommend the use of multi-target detection consisting of anti-dermcidin and anti-albumin when using immunolabeling as fingermark development technique. Additionally, the optimized multi-target approach was tested as a pre- and post-development technique in combination with powder dusting and cyanoacrylate fuming. Immunolabeling has not been implemented yet in forensic case work, however we expect that immunolabeling can be used to redevelop poorly developed and/or smudged fingermarks in the nearby future. Currently, an ongoing pilot-study is being conducted in collaboration with the Dutch police.